OrganiGram Global Logo
CA68617J1003

OrganiGram Global

Ins Portfolio
60% Chancen, 40% Gelassenheit. Aktien und Anleihen in einem LifeStrategy ETF. Jetzt entdecken
Anzeige

Kurse werden geladen...

 Anzeige

Prognose

Kaufen
  2
Halten
  2
Verkaufen
  0

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News


  • June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth

    As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasing consumer demand, introducing innovative products, and technological advancements in cultivation and production. Despite federal prohibition, 24 states have legalized adult-use cannabis, and 39 states have legalized medical cannabis. However, federal legalization efforts face challenges. In May 2025, the 1st U.S. Circuit Court of Appeals upheld the federal ban on marijuana, rejecting a legal challenge by several Massachusetts cannabis businesses. This decision underscores the ongoing tension between federal law and evolving state cannabis regulations. Additionally, while the Biden administration has proposed reclassifying marijuana to a less restricted category, the outcome remains uncertain, especially under a new administration.» Mehr auf marijuanastocks.com


  • Organigram Global Announces CEO Succession Plan

    TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the “Board”) to advance Organigram's strategic objectives, including.» Mehr auf businesswire.com


  • Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands

    Organigram Global reported record-high revenues for Q2 and improved net income. The company is now selling cannabis beverages in Canada and hemp-derived cannabis beverages in the US. Organigram Global is ramping up its facilities in Canada to meet international demand.» Mehr auf seekingalpha.com

Unternehmenszahlen

Im letzten Quartal hatte OrganiGram Global einen Umsatz von +42,14 Mio und ein Nettoeinkommen von +27,27 Mio
(EUR)März 2025
YOY
Umsatz+42,14 Mio63,42%
Bruttoeinkommen+11,83 Mio2.001,42%
Nettoeinkommen+27,27 Mio246,99%
EBITDA1,76 Mio89,24%

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+158,28 Mio
Anzahl Aktien
133,88 Mio
52 Wochen-Hoch/Tief
+1,82 - +0,74
DividendenNein
Beta
1,86
KGV (PE Ratio)
+14,18
KGWV (PEG Ratio)
+0,12
KBV (PB Ratio)
+0,61
KUV (PS Ratio)
+1,28

Unternehmensprofil

Name
OrganiGram Global
CEO
Beena G. Goldenberg
Mitarbeiter1.093

Assets entdecken

Shareholder von OrganiGram Global investieren auch in folgende Assets

🍪

Parqet nutzt Cookies.Erfahre Mehr